Department of Cardiology, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey.
EuroIntervention. 2010 Feb;5(7):821-5. doi: 10.4244/eijv5i7a137.
We report a new stenting technique which was employed in 12 patients to treat coronary bifurcation lesions.
A stent is positioned in the main vessel together with a balloon in the side branch, which is positioned slightly proximal to the main vessel stent that also has enough length to cover the side branch ostium. Both the stent in the main vessel and the balloon in the side branch are inflated simultaneously. Following deflation, a double lumen is created in the main vessel, proximal to the bifurcation. The stent balloon is removed with the side branch balloon left deflated in its initial position. The main vessel is rewired with a third guidewire. The side branch balloon and guidewire are removed. The initial guidewire in the main vessel is directed to the side branch. A balloon is advanced and inflated in the side branch to dilate the struts of the main vessel stent that will provide the side branch entrance. The side branch balloon is left in place. A size matched balloon is advanced on the third guidewire that was advanced in the main vessel and inflated inside the stent with high pressure. Finally, kissing balloon inflation is performed at the bifurcation. Provisional stenting of the side branch can be performed when necessary. Final kissing balloon inflation is recommended after stenting of the side branch.
As a new coronary bifurcation stenting method, the Highway Technique has some advantages in side branch protection, with favourable immediate and 30-day clinical outcomes.
我们报告了一种新的支架置入技术,12 例冠状动脉分叉病变患者采用该技术治疗。
将支架置于主血管内,同时将球囊置于分支血管内,分支血管球囊位于主血管支架的近端,且支架有足够的长度覆盖分支血管开口。主血管内的支架和分支血管内的球囊同时充气。充气完成后,在分叉近端的主血管内形成一个双腔。撤出主血管支架球囊,保留分支血管球囊处于初始位置。用第三根导丝重新进入主血管。撤出分支血管球囊和导丝。将初始导丝置于主血管的分支血管侧。推进一个球囊并在分支血管内充气,以扩张主血管支架的支柱,为分支血管入口提供支撑。保留分支血管球囊。将第三根导丝上的匹配球囊推进主血管支架内,用高压充气扩张。最后,在分叉处行对吻球囊扩张。必要时可对分支血管行预扩张支架术。建议在处理完分支血管后行最终的对吻球囊扩张。
作为一种新的冠状动脉分叉支架置入方法,Highway 技术在分支血管保护方面具有一些优势,即时和 30 天临床结果良好。